Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone.
Journal: Anticancer research
Published: October 30, 2025
Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone.
Journal: Anticancer research
Published: July 14, 2025
Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer.
Journal: Anticancer research
Published: December 05, 2023
The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years.
Journal: Expert review of endocrinology & metabolism
Published: January 17, 2023
Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators.
Journal: Anticancer research
Published: December 19, 2022
Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology.
Journal: Human reproduction (Oxford, England)
Published: July 12, 2022
New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor.
Journal: Anticancer research
Published: October 05, 2021
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Journal: International journal of molecular sciences
Published: September 22, 2021
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma.
Journal: Anticancer research
Published: February 13, 2021
Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
Journal: Anticancer research
Published: October 17, 2020
Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor.
Journal: Anticancer research
Published: February 01, 2019
Last Updated: 09/26/2026